Leti Startup to Provide Improved Cancer Surgery

Leti, a leading global research center committed to creating and commercializing innovation in micro- and nanotechnologies, announced today that it has launched a new company, Fluoptics, that will improve surgery of some types of cancers.

Combining technologies developed by Leti and Université Joseph Fourier in Grenoble, Fluoptics developed an innovative approach of fluorescence imaging for cancer targeting. This new real-time, imaging technique improves detection of tumors and helps surgeons to delineate it for exerese.

Fluoptics, the 30th startup launched by Leti, expects to commercialize its FluoBeam instrument in 2010 for pre-clinical research and begin regulatory the toxicity phases of its first fluorescent marker.

“Fluoptics not only exemplifies Leti’s mission of creating innovation and transferring it to industry, but it also is our first startup in the growing field of bio-medicine,” said Laurent Malier, CEO of Leti. “The company has great potential to improve the detection and treatment of cancer, and to have a real impact on the lives of cancer patients.”

“It is very difficult to distinguish between cancerous and healthy tissue, and our technology is the only intra-operative technique available to help surgeons precisely locate and delineate tumors,” said Odile Allard, CEO of Fluoptics. “Our incubation in Leti enabled the finalization of the laboratory prototype and its preclinical validation by surgeons specialized in cancer.”

Fluoptics, one of the four startups launched by Leti in the past year, will be based in MINATEC, Europe’s leading center of excellence in micro- and nanotechnologies.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CEA-Leti. (2019, March 19). Leti Startup to Provide Improved Cancer Surgery. AZoNano. Retrieved on May 24, 2024 from https://www.azonano.com/news.aspx?newsID=12115.

  • MLA

    CEA-Leti. "Leti Startup to Provide Improved Cancer Surgery". AZoNano. 24 May 2024. <https://www.azonano.com/news.aspx?newsID=12115>.

  • Chicago

    CEA-Leti. "Leti Startup to Provide Improved Cancer Surgery". AZoNano. https://www.azonano.com/news.aspx?newsID=12115. (accessed May 24, 2024).

  • Harvard

    CEA-Leti. 2019. Leti Startup to Provide Improved Cancer Surgery. AZoNano, viewed 24 May 2024, https://www.azonano.com/news.aspx?newsID=12115.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.